U.S. flag

An official website of the United States government

GTR Home > Genes

GCH1 GTP cyclohydrolase 1

Gene ID: 2643, updated on 18-Sep-2024
Gene type: protein coding
Also known as: GCH; DYT5; DYT14; DYT5a; GTPCH1; HPABH4B; GTP-CH-1

Summary

This gene encodes a member of the GTP cyclohydrolase family. The encoded protein is the first and rate-limiting enzyme in tetrahydrobiopterin (BH4) biosynthesis, catalyzing the conversion of GTP into 7,8-dihydroneopterin triphosphate. BH4 is an essential cofactor required by aromatic amino acid hydroxylases as well as nitric oxide synthases. Mutations in this gene are associated with malignant hyperphenylalaninemia and dopa-responsive dystonia. Several alternatively spliced transcript variants encoding different isoforms have been described; however, not all variants give rise to a functional enzyme. [provided by RefSeq, Jul 2008]

Associated conditions

See all available tests in GTR for this gene

DescriptionTests
Dystonia 5See labs
GTP cyclohydrolase I deficiency with hyperphenylalaninemia
MedGen: CN305333OMIM: 233910GeneReviews: Not available
See labs
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.
GeneReviews: Not available
Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population.
GeneReviews: Not available
Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.
GeneReviews: Not available

Copy number response

Description
Copy number response
Triplosensitivity

No evidence available (Last evaluated 2023-02-14)

ClinGen Genome Curation Page
Haploinsufficency

Sufficient evidence for dosage pathogenicity (Last evaluated 2023-02-14)

ClinGen Genome Curation PagePubMed

Genomic context

Location:
14q22.2
Sequence:
Chromosome: 14; NC_000014.9 (54842017..54902826, complement)
Total number of exons:
10

Links

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.